FNM-29031-89708
4 vaccinations
4 coded responses
33 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 175 / PA
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Dose 1 — Moderna
-
2021-02-28
Registered in v-safe
- 2021-02-28
- 2021-03-06
- 2021-03-13
-
2021-03-20
Dose 2 — Moderna
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-22
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Rash is on entire torso and backMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Good · Site: Pain, Redness, ItchingFree text: Still have rash on torso & back but is milder than yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-06-19
- 2021-09-18
-
2021-10-25
Dose 3 — Moderna
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Nausea, Abdominal pain, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Nausea, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
-
2021-12-06
Survey response — day 42, dose 3MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Cold-like symptoms - sore throat, runny nose, congestion, slight cough · Healthcare visit (other): Covid test - was negativeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-08
-
2022-01-24
Survey response — 3 months, dose 3MedDRA: Chills, Exposure to SARS-CoV-2, Headache, Pain, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2 weeks ago had fever, chills, body aches, & headache for 2 days after being exposed to someone who tested positive for COVID. I took 3 rapid at- home covid tests on days 2, 3, & 5 and all 3 results were negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Dose 4 — Moderna
- 2022-05-18
- 2022-07-01
- 2022-09-30
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Moderna | |
| 2 | 2021-03-20 | Moderna | |
| 3 | 2021-10-25 | Moderna | No |
| 4 | 2022-04-01 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Rash is on entire torso and back
Systemic reaction (other): Still have rash on torso & back but is milder than yesterday
Release 10 — day 42, dose 3
Symptoms: Cold-like symptoms - sore throat, runny nose, congestion, slight cough
Healthcare visit (other): Covid test - was negative
Release 11 — 3 months, dose 3
Symptoms: 2 weeks ago had fever, chills, body aches, & headache for 2 days after being exposed to someone who tested positive for COVID. I took 3 rapid at- home covid tests on days 2, 3, & 5 and all 3 results were negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release